Vaccines
Shingles, actually campaign
We are proud to partner with Viola Davis on Shingles, actually, a campaign that educates adults 50 years and older about shingles and their risk.
Behind the science US edition
Investors
We announced our second quarter 2026 results on Tuesday, 28 July.
Press releases
- Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer
- Viola Davis partners with GSK to educate adults 50 and older about their shingles risk
- Jemperli (dostarlimab-gxly) accepted for priority review by the US FDA for dMMR/MSI-H locally advanced rectal cancer
GSK Global links
Visit our Global site for additional features